Bayir Ece, Sendemir Aylin
Ege University Central Research Test and Analysis Laboratory Application and Research Center (EGE-MATAL), Izmir, Turkey.
Department of Bioengineering, Ege University, Izmir, Turkey.
Methods Mol Biol. 2021;2367:73-85. doi: 10.1007/7651_2020_344.
Blood-brain barrier (BBB), although very important for protection of brain from major neurotoxins, negatively affects the treatment of central nervous system diseases by limiting the passage of neuropharmaceuticals from blood to the brain. Thus, researchers have to investigate the passage of the produced drug molecules through the BBB before they are introduced to the market. Although these experiments have been traditionally performed on experimental animals, drug permeability tests are now carried out mostly by in vitro BBB models due to ethical problems, differences between species, and expensive and troublesome in vivo test procedures. In this method, we explain how to model and characterize a realistic in vitro BBB model using human derived cells and perform a drug permeability test using this model.
血脑屏障(BBB)虽然对于保护大脑免受主要神经毒素的侵害非常重要,但通过限制神经药物从血液进入大脑,对中枢神经系统疾病的治疗产生负面影响。因此,研究人员在将生产的药物分子推向市场之前,必须研究其通过血脑屏障的情况。尽管这些实验传统上是在实验动物身上进行的,但由于伦理问题、物种差异以及体内测试程序昂贵且麻烦,现在药物渗透性测试大多通过体外血脑屏障模型进行。在本方法中,我们将解释如何使用人源细胞构建和表征一个逼真的体外血脑屏障模型,并使用该模型进行药物渗透性测试。